2013
DOI: 10.1109/tmag.2012.2222020
|View full text |Cite
|
Sign up to set email alerts
|

Iron-Cobalt Ferrite Nanoparticles—Biocompatibility and Distribution After Intravenous Administration to Rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…Most of the studies are devoted to the cobalt ferrite MNPs biocompatibility investigation after i.v. administration [ 19 , 32 ]. However, the used concentrations of MNPs are often not sufficient to achieve the required temperatures for MHT.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the studies are devoted to the cobalt ferrite MNPs biocompatibility investigation after i.v. administration [ 19 , 32 ]. However, the used concentrations of MNPs are often not sufficient to achieve the required temperatures for MHT.…”
Section: Discussionmentioning
confidence: 99%
“…to the surface [15,16]. A study by Laznev et al revealed that, there were no significant difference in the cytotoxicity of CoFe 2 O 4 and polysiloxane surface coated CoFe 2 O 4 nanoparticles [17]. CoFe 2 O 4 nanoparticles were also revealed as promising nanocarriers in controlled drug delivery applications [18].…”
Section: Introductionmentioning
confidence: 99%